AUPH
Aurinia Pharmaceuticals Inc
Company Overview
| Mkt Cap | $1.71B | Price | $13.17 |
| Volume | 2.66M | Change | +8.66% |
| P/E Ratio | 296.7 | Open | $12.21 |
| Revenue | $235.1M | Prev Close | $12.12 |
| Net Income | $5.8M | 52W Range | $6.55 - $13.54 |
| Div Yield | N/A | Target | $11.71 |
| Overall | 70 | Value | 70 |
| Quality | 52 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyAurinia Pharmaceuticals Inc (AUPH) is a leading Healthcare company in the Biotechnology industry, currently trading at $13.17 with a market capitalization of $1.71 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AUPH with a volume of 2.66 million shares. The stock opened up 0.74% from yesterday's close of $12.12. Current analyst estimates project earnings of $0.62 per share for this year, with next year targeting $0.65.
AUPH demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including QURE, LXRX, IMUC, ONCY.
Key investment considerations for AUPH include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -11.1%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 02:06 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AUPH | $13.17 | +8.7% | 2.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aurinia Pharmaceuticals Inc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW